Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy

Clinical trial NCT05103306 · UNKNOWN

Trial details

NCT number: NCT05103306
Sponsor: Chungbuk National University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2017-01-01
Primary completion: 2022-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.